Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...

Chief Minister A. Revanth Reddy is set to inaugurate BioAsia 2026, the next edition of Asia’s leading life sciences and health-tech forum, in Hyderabad on February 17.

Sometimes it takes a combination of building pressures to spark a landslide of positive change. For pharmaceutical giant Bristol Myers Squibb (BMS), the moment came following its $74 billion ...

ICs and SoCs are utilizing a range of processing elements that allow them to optimize current workloads while hedging their bets for the future. What used to be a simple choice between an ASIC, FPGA, ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in Science Advances detailing the company's CRISPR-based Cellgorithm technology, ...

FRANKFURT, Nov 3 (Reuters) - Germany's BioNTech (22UAy.DE), opens new tab on Monday lifted its 2025 revenue guidance after receiving initial payments from its new partner Bristol Myers Squibb (BMY.N), ...

Nearly 4,500 Tesla Model 3 and Model Y owners in South Korea have complained about battery malfunctions that prevent charging. The problem, which primarily affects 2021 models, has drawn the scrutiny ...

The stars have aligned for Bristol Myers Squibb and Orbital Therapeutics. Pushing deeper into in vivo cell therapies, BMS has agreed to pay $1.5 billion to buy the biotech for a pipeline led by a ...

Bristol Myers Squibb is following in the footsteps of some of its big pharma company peers that have rolled out direct-to-patient online platforms offering branded drugs at steep discounts. When BMS ...

When I first encountered the concept of programmable money, I realized we weren’t just looking at an incremental upgrade to payments—we were witnessing the beginning of a complete re-architecture of ...